
Ishwaria Subbiah: If life’s in the journey and not the endpoint, then preparing our patients and caregivers for the EVP journey is the top priority!
Ishwaria Subbiah shared on Twitter:
“Wow! That OS w EVP! This wait for approval is the perfect time to put your symptom management teams on alert! Because these patients will need it. EVP’s low-grade AEs are exactly why PRO results MUST be reported out with the primary outcome and patients preparing pts and caregivers for the EVP journey is priority #1! Here’s why:
- 50% had ‘low grade’ peripheral sensory neuropathy. FYI Grade 2 is “moderate symptoms; limiting instrumental ADL (IADLs).”
- 40% had ‘low grade’ pruritus. FYI Grade 2 pruritus is “widespread & intermittent; skin changes from scratching (eg edema, papulation, excoriations, lichenification, oozing/crusts); oral intervention indicated; limiting IADL”
- 33% had ‘low grade’ alopecia. FYI Grade 2 alopecia is “Hair loss of >=50%…readily apparent to others; a wig or hair piece is necessary if desired; associated with psychosocial impact.” Gr 2 is the max — there’s no gr 3/4/5.
- 33% had ‘low grade’ maculopapular rash. FYI Grade 2 is “Macules/papules covering 10 – 30% BSA w or wo symptoms (e.g., pruritus, burning, tightness); limiting IADLs; rash covering > 30% BSA w or wo mild symptoms”
- 29% had ‘low grade’ fatigue. Grade 2 fatigue is ” Fatigue not relieved by rest; limiting IADLs.”
- 28% had ‘low grade’ diarrhea. Grade 2 diarrhea is “Increase of 4 – 6 stools per day over baseline; moderate increase in ostomy output compared to baseline; limiting IADLs”
FYI for the lay persons: Instrumental activities of daily living (IADLs) are things you do to take care of yourself and your home, such as:
- Use the phone, answering and calling others.
- Shop for groceries on your own.
- Plan, heat, serve your own meals.
- Manage your meds, refill them as needed, take them correctly.
- Clean your home on your own.
- Get around on your own by car, taxi, or public transportation.
- Manage money and pay bills.
Practice-changing — yes! in that we ensure we prepare our patients and caregivers not just for the possibility of a longer life (!) but also for the management of side effects! Every disrupted IADL may have major consequences for a patient and family:
- Significant rise in caregiver burden – imagine the IADLs falling solely on the working caregiver, with young kids, indefinitely);
- Impact on independence and in turn, job security. i.e. trouble driving to work? needing to cut back work hours from that fatigue, diarrhea, neuropathy, etc.?;
- Changes in everyday life from perceptible physical changes inc. hair loss, widespread rash, plus active symptoms of neuropathy, diarrhea, fatigue, etc. all impact social interactions and support.
One more time: If life’s in the journey and not the endpoint, then preparing our patients and caregivers for the EVP journey is the top priority! “
Source: Ishwaria Subbiah/Twitter
Ishwaria Subbiah is the Executive Director for Cancer Care Equity and Professional Wellness at Sarah Cannon Research Institute (SCRI). In this role, Dr. Subbiah focuses on reducing cancer outcomes disparities and diversifying clinical trial participation within SCRI’s combined research network of over more than 1,300 physicians at over 250 locations in 24 states across the US. Dr. Subbiah is a globally recognized expert in geriatric oncology, symptom management, palliative care, and healthcare professional well-being. She previously was an associate professor in the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center. She is the Chair for the ASCO Women in Oncology working group and the ASCO State of Cancer Care in America initiative.
-
Dec 8, 2023, 17:10 | OpinionAaron Goodman: Let’s stop giving many cured young patients neuropathy
-
Dec 8, 2023, 16:29 | BlogBecome a SIOP member today or renew for 2024 membership year - SIOP
-
Dec 8, 2023, 15:51 | BlogSharon Kapambwe: Standing on the shoulders of giants- Professor Lynnette Denny
-
Dec 8, 2023, 12:47 | InsightTalha Badar: A few selected ALL abstracts to watch for at ASH23
-
Dec 9, 2023, 04:44President Biden: It's good for the millions of Americans who can't afford their medications
-
Dec 8, 2023, 17:40Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
-
Dec 8, 2023, 17:32Daniel Stover: Tumor genomic testing (TGT) is standard for MBC patients
-
Dec 8, 2023, 12:47Talha Badar: A few selected ALL abstracts to watch for at ASH23
-
Dec 8, 2023, 12:40Amar Kelkar: We hope putting out independent cost-effectiveness analyses like this will encourage others to join
-
Dec 8, 2023, 16:33Big thank you to Dr. Rucha Kiran Patil for sharing their experiences and learnings on writing abstracts and poster presentations - Novo Nordisk Haemophilia Foundation
-
Dec 6, 2023, 14:57Tracy Gosselin: Jennifer Petruno Receives DAISY Award for Extraordinary Nurses
-
Dec 3, 2023, 16:34Tedros Adhanom Ghebreyesus: Grateful to Namibia’s Prime Minister Saara Kuugongelwa-Amadhila for her commitment to health
-
Dec 2, 2023, 18:08100 Influential Celebrities in Oncology: The 2023 Edition – Part 5
-
Dec 2, 2023, 16:50Mara Antonoff: When your famous friends come back to visit their humble beginnings
-
Dec 4, 2023, 16:26SIOP 2023 by Numbers! - International Society of Paediatric Oncology
-
Dec 2, 2023, 16:43In our recent survey, nearly 1,700 ASCO members shared feedback on the ABIM MOC requirements - ASCO
-
Nov 28, 2023, 17:34The International Association of Cancer Registries annual conference - IARC
-
Nov 26, 2023, 18:05Submit your abstract by 13 February for ESMO-Breast-24 - ESMO
-
Nov 26, 2023, 17:58Lisa A. Lacasse: My sincere gratitude to the ACS CAN team, our incredible volunteers, and supporters for another outstanding year
-
Dec 8, 2023, 17:54Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
-
Dec 8, 2023, 17:35Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity
-
Dec 7, 2023, 18:30Dinesh Pendharkar is appointed as an Adjunct Professor at Roswell Park Comprehensive Cancer Center
-
Dec 7, 2023, 04:37Karun Neupane: Dreams do come true. I am going to Moffitt Cancer Center to become a hematologist/oncologist!
-
Dec 6, 2023, 16:21Sandra L. Wong has been appointed the next Dean of Emory University School of Medicine and chief academic officer for Emory Healthcare - Emory School of Medicine